Low Frequency of Cytotoxic T Lymphocytes against the Novel HLA-A*0201-Restricted JC Virus Epitope VP1p36 in Patients with Proven or Possible Progressive Multifocal Leukoencephalopathy

Journal of Virology

Volumn 77, Issue 22, 2003, Pages 11918-11926

  Du Pasquier, Renaud A ^a   Kuroda, Marcelo J ^a   Schmitz, Joern E ^a   Zheng, Yue ^a   Martin, Kristi ^a   Peyerl, Fred W ^a   Lifton, Michelle ^a   Gorgone, Darci ^a   Autissier, Patrick ^a   Letvin, Norman L ^a   Koralnik, Igor J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CHROMIUM 51; EPITOPE; HLA A ANTIGEN; PEPTIDE; PROTEIN VP1; SERYLISOLEUCYLTHREONYLGLUTAMYLVALYLGLUTAMYLCYSTEINYLPHENYLALANYLLEUCINE; TETRAMER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL SELECTION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; FRESH BLOOD TETRAMER STAINING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOMAGNETIC SEPARATION; JC VIRUS; MEMORY CELL; MONONUCLEAR CELL; NONHUMAN; OUTCOMES RESEARCH; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; STAINING;

CAPSID PROTEINS; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HUMANS; IMMUNOPHENOTYPING; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0242331748     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.22.11918-11926.2003     Document Type: Article

References (35)

1. Agostini, H. T., C. F. Ryschkewitsch, E. J. Singer, R. W. Baumhefner, and G. L. Stoner. 1998. JC virus type 2B is found more frequently in brain tissue of progressive multifocal leukoencephalopathy patients than in urine from controls. J. Hum. Virol. 1:200-206.
2. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94-96.
3. Ammassari, A., A. Cingolani, P. Pezzotti, D. A. De Luca, R. Murri, M. L. Giancola, L. M. Larocca, and A. Antinori. 2000. AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 55:1194-1200.
4. Ault, G. S., and G. L. Stoner. 1992. Two major types of JC virus defined in progressive multifocal leukoencephalopathy brain by early and late coding region DNA sequences. J. Gen. Virol. 73:2669-2678.
5. Berger, J. R., R. M. Levy, D. Flomenhoft, and M. Dobbs. 1998. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann. Neurol. 44:341-349.
6. Boppana, S. B., and W. J. Britt. 1996. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells. Virology 222:293-296.
7. Borysiewicz, L. K., S. Morris, J. D. Page, and J. G. Sissons. 1983. Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity. Eur. J. Immunol. 13:804-809.
8. Cao, K., J. Hollenbach, X. Shi, W. Shi, M. Chopek, and M. A. Fernandez-Vina. 2001. Analysis of the frequencies of HLA-A, -B, and -C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum. Immunol. 62:1009-1030.
9. Cinque, P., C. Pierotti, M. G. Vigano, A. Bestetti, C. Fausti, D. Bertelli, and A. Lazzarin. 2001. The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy. J. Neurovirol. 7:358-363.
10. Cinque, P., I. J. Koralnik, and D. Clifford. 2003. The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus for terminology. J. Neurovirol. 9:88-92.
11. Du Pasquier, R. A., K. W. Clark, P. S. Smith, J. T. Joseph, J. M. Mazullo, U. De Girolami, N. L. Letvin, and I. J. Koralnik. 2001. Favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy correlates with JCV-specific cellular immune response. J. Neurovirol. 7:318-322.
12. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290-296.
13. Frisque, R. J., G. L. Bream, and M. T. Cannella. 1984. Human polyomavirus JC virus genome. J. Virol. 51:458-469.
14. Garboczi, D. N., D. T. Hung, and D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89:3429-3433.
15. + patients with progressive multifocal leukoencephalopathy, anti-JC virus CD4 T-cell responses are recovered following prolonged HAART. Fourth International Symposium on Neurovirology and 10th Conference on Neuroscience of HIV Infection, Dusseldorf, Germany.
16. Hunt, D. F., R. A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A. L. Cox, E. Appella, and V. H. Engelhard. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261-1263.
17. Koralnik, I. J., D. Boden, V. X. Mai, C. I. Lord, and N. L. Letvin. 1999. JC virus DNA load in patients with or without progressive multifocal leukoencephalopathy. Neurology 52:253-260.
18. Koralnik, I. J., R. A. Du Pasquier, and N. L. Letvin. 2001. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J. Virol. 75:3483-3487.
19. + progressive multifocal leukoencephalopathy patients with a cytotoxic T lymphocyte response specific for a dominant JC virus epitope. J. Immunol. 168:499-504.
20. + T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood 98:1872-1881.
21. McDermott, A. B., H. M. Spiegel, J. Irsch, G. S. Ogg, and D. F. Nixon. 2001. A simple and rapid magnetic bead separation technique for the isolation of tetramer-positive virus-specific CD8 T cells. AIDS 15:810-812.
22. Miller, M. D., C. I. Lord, V. Stallard, G. P. Mazzara, and N. L. Letvin. 1990. The gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques. J. Immunol. 144:122-128.
23. Miltenyi, S., W. Muller, W. Weichel, and A. Radbruch. 1990. High gradient magnetic cell separation with MACS. Cytometry 11:231-238.
24. + T lymphocytes. Proc. Natl. Acad. Sci. USA 97:3382-3387.
25. Padgett, B. L., D. L. Walker, G. M. ZuRhein, R. J. Eckroade, and B. H. Dessel. 1971. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet i:1257-1260.
26. Parker, K. C., M. A. Bednarek, L. K. Hull, U. Utz, B. Cunningham, H. J. Zweerink, W. E. Biddison, and J. E. Coligan. 1992. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J. Immunol. 149:3580-3587.
27. + cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J. Virol. 70:8165-8168.
28. Power, C., J. G. Gladden, W. Halliday, M. R. Del Bigio, A. Nath, W. Ni, E. O. Major, J. Blanchard, and M. Mowat. 2000. AIDS- and non-AIDS-related PML association with distinct p53 polymorphism. Neurology 54:743-746.
29. Rickinson, A. B., D. J. Moss, D. J. Allen, L. E. Wallace, M. Rowe, and M. A. Epstein. 1981. Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line. Int. J. Cancer 27:593-601.
30. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2. 1 molecules. Cell 74:929-937.
31. Seth, A., J. Markee, A. Hoering, A. Sevin, D. E. Sabath, J. E. Schmitz, M. J. Kuroda, M. A. Lifton, M. S. Hirsch, A. C. Collier, N. L. Letvin, and M. J. McElrath. 2001. Alterations in T-cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy. J. Infect. Dis. 183:722-729.
32. + T cells specific for EBV in healthy virus carriers. J. Immunol. 162:1827-1835.
33. Weber, F., C. Goldmann, M. Kramer, F. J. Kaup, M. Pickhardt, P. Young, H. Petry, T. Weber, and W. Luke. 2001. Cellular and humoral immune response in progressive multifocal leukoencephalopathy. Ann. Neurol. 49:636-642.
34. Weber, T., C. Trebst, S. Frye, P. Cinque, L. Vago, C. J. Sindic, W. J. Schulz-Schaeffer, H. A. Kretzschmar, W. Enzensberger, G. Hunsmann, and W. Luke. 1997. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J. Infect. Dis. 176:250-254.
35. Wills, M. R., A. J. Carmichael, K. Mynard, X. Jin, M. P. Weekes, B. Plachter, and J. G. Sissons. 1996. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 70:7569-7579.